Previous 10 | Next 10 |
MOUNTAIN VIEW, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended March 28, 2020. Commenting on the recently completed quarter and the business environment created by the COVID-19 pandemic, David I. Bruc...
MOUNTAIN VIEW, Calif., April 28, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the first quarter of 2020 after the close of trading on Monday, May 11, 2020. The Company’s management team will host a correspon...
MOUNTAIN VIEW, Calif. , April 21, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the appointment of Doris Engibous to its board of directors effe...
MOUNTAIN VIEW, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Romeo Dizon has retired from his position as Vice President ...
IRIDEX Corp (IRIX) Q4 2019 Earnings Conference Call March 12, 2020, 17:00 ET Company Participants Leigh Salvo - Head, IR David Bruce - President, CEO & Director Romeo Dizon - VP, Finance & Controller Conference Call Participants Jonathan Block - Stifel, Nicolaus &am...
MOUNTAIN VIEW, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter ended December 28, 2019. Fourth Quarter Highlights Cyclo G6® product family revenue grew 18% year-over-year to $3.7 million, or 3...
MOUNTAIN VIEW, Calif., Feb. 28, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year of 2019 after the close of trading on Thursday, March 12, 2020. The Company’s management te...
MOUNTAIN VIEW, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today the introduction of the second generation of the MicroPulse P3 ...
Gainers: FLNT +59.8% . OGI +27.8% . APTX +9.3% . MNTA +4.8% . OTCQB:CURR +2.0% . More news on: Fluent, Inc., OrganiGram Holdings Inc., Aptinyx Inc., Stocks on the move, , Read more ...
Gainers: RTI Surgical RTIX +66% . More news on: IRIDEX Corporation, Inpixon, Gritstone Oncology, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial resul...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...